These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27388234)

  • 1. Cardiogenic Shock and Respiratory Failure in a Patient With Metastatic Melanoma Receiving Trametinib Therapy.
    Tseng D; Mason XL; Neilan TG; Sullivan RJ
    Oncologist; 2016 Sep; 21(9):1136-7. PubMed ID: 27388234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pomalidomide, dabrafenib mesylate, and trametinib dimethyl sulfoxide.
    Hussar DA; Kaminski JL
    J Am Pharm Assoc (2003); 2013; 53(5):550-8. PubMed ID: 24030134
    [No Abstract]   [Full Text] [Related]  

  • 3. Tattoo-associated complications of metastatic melanoma treated with dabrafenib and trametinib.
    Laske J; Meier F; Bauer A; Beissert S; Garzarolli M
    Melanoma Res; 2018 Oct; 28(5):485-487. PubMed ID: 30148769
    [No Abstract]   [Full Text] [Related]  

  • 4. Vemurafenib/dabrafenib and trametinib.
    Rissmann R; Hessel MH; Cohen AF
    Br J Clin Pharmacol; 2015 Oct; 80(4):765-7. PubMed ID: 25847075
    [No Abstract]   [Full Text] [Related]  

  • 5. Dabrafenib and trametinib, alone and in combination for BRAF-mutant metastatic melanoma.
    Menzies AM; Long GV
    Clin Cancer Res; 2014 Apr; 20(8):2035-43. PubMed ID: 24583796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute heart failure as a result of granulomatous myocarditis: case report on a patient with metastatic melanoma treated with dabrafenib and trametinib.
    Winkler JK; Buder-Bakhaya K; Ellert E; Herpel E; Martens UM; Enk A; Hassel JC
    J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):e31-e32. PubMed ID: 28695986
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.
    Grob JJ; Amonkar MM; Karaszewska B; Schachter J; Dummer R; Mackiewicz A; Stroyakovskiy D; Drucis K; Grange F; Chiarion-Sileni V; Rutkowski P; Lichinitser M; Levchenko E; Wolter P; Hauschild A; Long GV; Nathan P; Ribas A; Flaherty K; Sun P; Legos JJ; McDowell DO; Mookerjee B; Schadendorf D; Robert C
    Lancet Oncol; 2015 Oct; 16(13):1389-98. PubMed ID: 26433819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival with MEK inhibition in BRAF-mutated melanoma.
    Flaherty KT; Robert C; Hersey P; Nathan P; Garbe C; Milhem M; Demidov LV; Hassel JC; Rutkowski P; Mohr P; Dummer R; Trefzer U; Larkin JM; Utikal J; Dreno B; Nyakas M; Middleton MR; Becker JC; Casey M; Sherman LJ; Wu FS; Ouellet D; Martin AM; Patel K; Schadendorf D;
    N Engl J Med; 2012 Jul; 367(2):107-14. PubMed ID: 22663011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trametinib in metastatic melanoma.
    Chopra N; Nathan PD
    Expert Rev Anticancer Ther; 2015; 15(7):749-60. PubMed ID: 26107021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dabrafenib (Tafinlar) and trametinib (Mekinist) metastatic melanoma.
    Med Lett Drugs Ther; 2013 Aug; 55(1422):62-3. PubMed ID: 23917385
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic hemorrhage as a consequence of rapid response to combined targeted therapy in metastatic melanoma.
    Flaherty DC; Hoffner BW; Lau BJ; Hamid O; Faries MB
    J Surg Oncol; 2015 Dec; 112(8):844-5. PubMed ID: 26503563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective treatment with Dabrafenib and Trametinib for a BRAF-mutated metastatic dedifferentiated malignant spindle cell neoplasm.
    Escandell I; Cabezas M; Martín JM; Terradez L; Pinazo MI
    J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1224-6. PubMed ID: 25917403
    [No Abstract]   [Full Text] [Related]  

  • 13. Dropped-head syndrome in a patient under treatment with the MEK inhibitor trametinib for NRAS-mutated metastatic melanoma.
    Kleemann J; Hrgovic I; Hempel K; Kaufmann R; Meissner M
    Clin Exp Dermatol; 2018 Mar; 43(2):195-196. PubMed ID: 29023842
    [No Abstract]   [Full Text] [Related]  

  • 14. Features and management of pyrexia with combined dabrafenib and trametinib in metastatic melanoma.
    Lee CI; Menzies AM; Haydu LE; Azer M; Clements A; Kefford RF; Long GV
    Melanoma Res; 2014 Oct; 24(5):468-74. PubMed ID: 25054915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe gastrointestinal toxicity with administration of trametinib in combination with dabrafenib and ipilimumab.
    Minor DR; Puzanov I; Callahan MK; Hug BA; Hoos A
    Pigment Cell Melanoma Res; 2015 Sep; 28(5):611-2. PubMed ID: 25996827
    [No Abstract]   [Full Text] [Related]  

  • 16. [Response of BRAF(L597Q)-mutant melanoma to trametinib : Targeted melanoma therapy beyond BRAF(V600) mutations].
    Haase O; Angün O; Grätz V; Lüttmann N; Neumann A; Zillikens D; Terheyden P
    Hautarzt; 2016 Aug; 67(8):648-52. PubMed ID: 27146499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the MEK inhibitor trametinib in the treatment of metastatic melanoma.
    King JW; Nathan PD
    Future Oncol; 2014; 10(9):1559-70. PubMed ID: 25145427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanoma.
    Schadendorf D; Amonkar MM; Stroyakovskiy D; Levchenko E; Gogas H; de Braud F; Grob JJ; Bondarenko I; Garbe C; Lebbe C; Larkin J; Chiarion-Sileni V; Millward M; Arance A; Mandalà M; Flaherty KT; Nathan P; Ribas A; Robert C; Casey M; DeMarini DJ; Irani JG; Aktan G; Long GV
    Eur J Cancer; 2015 May; 51(7):833-40. PubMed ID: 25794603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facing the challenges of new melanoma-targeted therapies: Treatment of severe fevers associated with dabrafenib/trametinib combination therapy.
    Lindsay JN; Barras M
    J Oncol Pharm Pract; 2015 Aug; 21(4):293-5. PubMed ID: 24664475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dabrafenib plus Trametinib: a Review in Advanced Melanoma with a BRAF (V600) Mutation.
    Dhillon S
    Target Oncol; 2016 Jun; 11(3):417-28. PubMed ID: 27246822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.